|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 4:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Jemal A, Center MM, DeSantis C and Ward
EM: Global patterns of cancer incidence and mortality rates and
trends. Cancer Epidemiol Biomarkers Prev. 190:1893–1907.
2010.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Saito R, Kobayashi T, Kashima S, Matsumoto
K and Ogawa O: Faithful preclinical mouse models for better
translation to bedside in the field of immuno-oncology. Int J Clin
Oncol. 25:831–841. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Tsumura R, Koga Y, Hamada A, Kuwata T,
Sasaki H, Doi T, Aikawa K, Ohashi A, Katano I, Ikarashi Y, et al:
Report of the use of patient-derived xenograft models in the
development of anticancer drugs in Japan. Cancer Sci.
111:3386–3394. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Braekeveldt N and Bexell D:
Patient-derived xenografts as preclinical neuroblastoma models.
Cell Tissue Res. 372:233–243. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mak IW, Evaniew N and Ghert M: Lost in
translation: Animal models and clinical trials in cancer treatment.
Am J Transl Res. 6:114–118. 2014.PubMed/NCBI
|
|
7
|
Jin K, Teng L, Shen Y, He K, Xu Z and Li
G: Patient-derived human tumour tissue xenografts in
immunodeficient mice: A systematic review. Clin Transl Oncol.
12:473–480. 2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zhu Y, Tian T, Li Z, Tang Z, Wang L, Wu J,
Li Y, Dong B, Li Y, Li N, et al: Establishment and characterization
of patient-derived tumor xenograft using gastroscopic biopsies in
gastric cancer. Sci Rep. 5(8542)2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Fichtner I, Rolff J, Soong R, Hoffmann J,
Hammer S, Sommer A, Becker M and Merk J: Establishment of
patient-derived non-small cell lung cancer xenografts as models for
the identification of predictive biomarkers. Clin Cancer Res.
14:6456–6468. 2008.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Chijiw T, Kawai K, Noguchi A, Sato H,
Hayashi A, Cho H, Shiozawa M, Kishida T, Morinaga S, Yokose T, et
al: Establishment of patient-derived cancer xenografts in
immunodeficient NOG mice. Int J Oncol. 47:61–70. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Morton CL and Houghton PJ: Establishment
of human tumor xenografts in immunodeficient mice. Nat Protoc.
2:247–250. 2007.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Lee CH, Xue H, Sutcliffe M, Gout PW,
Huntsman DG, Miller DM, Gilks CB and Wang YZ: Establishment of
subrenal capsule xenografts of primary human ovarian tumors in SCID
mice: Potential models. Gynecol Oncol. 96:48–55. 2005.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Shultz LD, Goodwin N, Ishikawa F, Hosur V,
Lyons BL and Greiner DL: Human cancer growth and therapy in
immunodeficient mouse models. Cold Spring Harb Protoc. 1:694–708.
2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhou Q, Facciponte J, Jin M, Shen Q and
Lin Q: Humanized NOD- SCIDIL-2rg-/- mice as a preclinical model for
cancer research and its potential use for individualized cancer
therapies. Cancer Lett. 344:13–19. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Hogenes M, Huibers M, Kroone C and de Wege
R: Humanized mouse models in transplantation research. Transplant
Rev (Orlando). 28:103–110. 2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Shultz LD, Lyons BL, Burzenski LM, Gott B,
Chen X, Chaleff S, Kotb M, Gillies SD, King M, Mangada J, et al:
Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R
gamma null mice engrafted with mobilized human hemopoietic stem
cells. J Immunol. 174:6477–6489. 2005.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ito M, Hiramatsu H, Kobayashi K, Suzue K,
Kawahata M, Hioki K, Ueyama Y, Koyanagi Y, Sugamura K, Tsuji K, et
al: NOD/SCID/gamma(c)(null) mouse: An excellent recipient mouse
model for engraftment of human cells. Blood. 100:3175–3182.
2002.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Foreman O, Kavirayani AM, Griffey SM,
Reader R and Shultz LD: Opportunistic bacterial infections in
breeding colonies of the NSG mouse strain. Vet Pathol. 48:495–499.
2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Brehm MA, Cuthbert A, Yang C, Miller DM,
DiIorio P, Laning J, Burzenski L, Gott B, Foreman O, Kavirayani A,
et al: Parameters for establishing humanized mouse models to study
human immunity: Analysis of human hematopoietic stem cell
engraftment in three immunodeficient strains of mice bearing the
IL2rgamma(null) mutation. Clin Immunol. 135:84–98. 2010.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Hiroshima Y, Zhang Y, Zhang N, Uehara F,
Maawy A, Murakami T, Mii S, Yamamoto M, Miwa S, Yano S, et al:
Patient-derived orthotopic xenograft (PDOX) nude mouse model of
soft-tissue sarcoma more closely mimics the patient behavior in
contrast to the subcutaneous ectopic model. Anticancer Res.
35:697–701. 2015.PubMed/NCBI
|
|
21
|
Sun P, Jin R, Du X, Xu Y, Sun H and Li R:
Establishment of a nude mouse model of orthotopic engineered
gastric tumor and its in vivo fluorescence imaging. Nan Fang Yi Ke
Da Xue Xue Bao. 32:1718–1721. 2012.PubMed/NCBI(In Chinese).
|
|
22
|
Read M, Bernardi MP, Liu D, et al: Mo 1933
Development of esophageal and anal cancer patient derived tumor
xenograft (PDTX) models using a novel implantation technique.
Gastroenterology. 146 (5 Suppl 1)(S695)2014.
|
|
23
|
Blocker SJ, Mowery YM, Holbrook MD, Qi Y,
Kirsch DG, Johnson GA and Badea CT: Bridging the translational gap:
Implementation of multimodal small animal imaging strategies for
tumor burden assessment in a co-clinical trial. PLoS One.
8(e0207555)2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Razansky D, Deliolanis NC, Vinegoni C and
Ntziachristos V: Deep tissue optical and optoacoustic molecular
imaging technologies for pre-clinical research and drug discovery.
Curr Pharm Biotechnol. 13:504–522. 2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ivanics T, Bergquist JR, Liu G, Kim MP,
Kang Y, Katz MH, Perez MVR, Thomas RM, Fleming JB and Truty MJ:
Patient-derived xenograft cryopreservation and reanimation outcomes
are dependent on cryoprotectant type. Lab Invest. 98:947–956.
2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ramachandran H, Laux J, Moldovan I,
Caspell R, Lehmann PV and Subbramanian RA: Optimal thawing of
cryopreserved peripheral blood mononuclear cells for use in
high-throughput human immune monitoring studies. Cells. 25:313–324.
2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zhang XC, Zhang J, Li M, Huang XS, Yang
XN, Zhong WZ, Xie L, Zhang L, Zhou M, Gavine P, et al:
Establishment of patient-derived non-small cell lung cancer
xenograft models with genetic aberrations within EGFR, KRAS and
FGFR1: Useful tools for preclinical studies of targeted therapies.
J Transl Med. 11(168)2013.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Anderson WC, Boyd MB, Aguilar J, Pickell
B, Laysang A, Pysz MA, Bheddah S, Ramoth J, Slingerland BC, Dylla
SJ and Rubio ER: Initiation and characterization of small cell lung
cancer patient-derived xenografts from ultrasound-guided
transbronchial needle aspirates. PLoS One.
10(e0125255)2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Okada S, Vaeteewoottacharn K and Kariya R:
Establishment of a patient-derived tumor xenograft model and
application for precision cancer medicine. Chem Pharm Bull (Tokyo).
66:225–230. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wang CF and Shi XJ: Generation and
application of patient-derived xenograft models in pancreatic
cancer research. Chin Med J (Engl). 132:2729–2736. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Hidalgo M, Bruckheimer E, Rajeshkumar NV,
Garrido-Laguna I, De Oliveira E, Rubio-Viqueira B, Strawn S, Wick
MJ, Martell J and Sidransky D: A pilot clinical study of treatment
guided by personalized tumorgrafts in patients with advanced
cancer. Mol Cancer Ther. 10:1311–1316. 2011.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Bian B, Bigonnet M, Gayet O, Loncle C,
Maignan A, Gilabert M, Moutardier V, Garcia S, Turrini O, Delpero
JR, et al: Gene expression profiling of patient-derived pancreatic
cancer xenografts predicts sensitivity to the BET bromodomain
inhibitor JQ1: Implications for individualized medicine efforts.
EMBO Mol Med. 9:482–497. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Bissig-Choisat B, Kettlun-Leyton C, Legras
XD, Zorman B, Barzi M, Chen LL, Amin MD, Huang YH, Pautler RG,
Hampton OA, et al: Novel patient-derived xenograft and cell line
models for therapeutic testing of pediatric liver cancer. J
Hepatol. 65:325–333. 2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Dang SC, Fan YY, Cui L, Chen JX, Qu JG and
Gu M: PLK1 as a potential prognostic marker of gastric cancer
through MEK-ERK pathway on PDTX models. Onco Targets Ther.
11:6239–6247. 2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Yang H, Li X, Meng Q, Sun H, Wu S, Hu W,
Liu G, Li X, Yang Y and Chen R: CircPTK2 (hsa_circ_0005273) as a
novel therapeutic target for metastatic colorectal cancer. Mol
Cancer. 19(13)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Bertotti A, Migliardi G, Galimi F, Sassi
F, Torti D, Isella C, Corà D, Di Nicolantonio F, Buscarino M, Petti
C, et al: A molecularly annotated platform of patient- derived
xenografts (‘xenopatients’) identifies HER2 as an effective
therapeutic target in cetuximab-resistant colorectal cancer. Cancer
Discov. 1:508–523. 2011.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Guerreschi P, Scalbert C, Qassemyar A,
Kluza J, Ravasi L, Huglo D, Martinot-Duquennoy V, Formstecher P,
Marchetti P and Mortier L: Patient-derived tumor xenograft model to
guide the use of BRAF inhibitors in metastatic melanoma. Melanoma
Res. 23:373–380. 2013.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Whiteside TL, Demaria S, Rodriguez-Ruiz
ME, Zarour HM and Melero I: Emerging opportunities and challenges
in cancer immunotherapy. Clin Cancer Res. 22:1845–1855.
2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
De La Rochere P, Guil-Luna S, Decaudin D,
Azar G, Sidhu SS and Piaggio E: Humanized mice for the study of
immuno-oncology. Trends Immunol. 39:748–763. 2018.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Lee HW, Chung W, Lee HO, Jeong DE, Jo A,
Lim JE, Hong JH, Nam DH, Jeong BC, Park SH, et al: Single-cell RNA
sequencing reveals the tumor microenvironment and facilitates
strategic choices to circumvent treatment failure in a
chemorefractory bladder cancer patient. Genome Med.
27(47)2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Yao LC, Aryee KE, Cheng M, Kaur P, Keck JG
and Brehm MA: Creation of PDX-bearing humanized mice to study
immuno-oncology. Methods Mol Biol. 1953:241–252. 2019.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Morton JJ, Bird G, Keysar SB, Astling DP,
Lyons TR, Anderson RT, Glogowska MJ, Estes P, Eagles JR and Le PN:
XactMice: Humanizing mouse bone marrow enables microenvironment
reconstitution in a patient-derived xenograft model of head and
neck cancer. Oncogene. 35:290–300. 2016.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Sharpe AH and Pauken KE: The diverse
functions of the PD1 inhibitory pathway. Nat Rev Immunol.
18:153–167. 2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Capasso A, Lang J, Pitts TM, Jordan KR,
Lieu CH, Davis SL, Diamond JR, Kopetz S, Barbee J, Peterson J, et
al: Characterization of immune responses to anti-PD-1 mono and
combination immunotherapy in hematopoietic humanized mice implanted
with tumor xenografts. J Immunother Cancer. 8(37)2019.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Rivera M, Fichtner I, Wulf-Goldenberg A,
Sers C, Merk J, Patone G, Alp KM, Kanashova T, Mertins P, Hoffmann
J, et al: Patient-derived xenograft (PDX) models of colorectal
carcinoma (CRC) as a platform for chemosensitivity and biomarker
analysis in personalized medicine. Neoplasia. 23:21–35.
2021.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Cutz JC, Guan J, Bayani J, Yoshimoto M,
Xue H, Sutcliffe M, English J, Flint J, LeRiche J, Yee J, et al:
Establishment in severe combined immunodeficiency mice of subrenal
capsule xenografts and transplantable tumor lines from a variety of
primary human lung cancers: Potential models for studying tumor
progression-related changes. Clin Cancer Res. 12:4043–4054.
2006.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Choi SI, Jeon AR, Kim MK, Lee YS, Im JE,
Koh JW, Han SS, Kong SY, Yoon KA, Koh YH, et al: Development of
patient-derived preclinical platform for metastatic pancreatic
cancer: PDOX and a subsequent organoid model system using
percutaneous biopsy samples. Front Oncol. 13(875)2019.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Read M, Liu D, Duong CP, Cullinane C,
Murray WK, Fennell CM, Shortt J, Westerman D, Burton P, Clemons NJ
and Phillips WA: Intramuscular transplantation improves engraftment
rates for esophageal patient-derived tumor xenografts. Ann Surg
Oncol. 2:305–311. 2016.PubMed/NCBI View Article : Google Scholar
|
